Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 1A1 (CYP1A1) is a member of the cytochrome P450 superfamily of enzymes involved in the metabolism of drugs, xenobiotics, and endogenous compounds. It is primarily found in extrahepatic tissues and is inducible by polycyclic aromatic hydrocarbons (PAHs). CYP1A1 can both activate procarcinogens into carcinogenic metabolites and detoxify certain compounds, playing a complex role in cancer development. Genetic polymorphisms can affect its inducibility and influence cancer susceptibility. It metabolizes endogenous substrates such as fatty acids, steroid hormones, vitamins (notably retinoic acid), and eicosanoids.
CYP1A1 is a monooxygenase that catalyzes the oxidation of various substrates, including xenobiotics and endogenous compounds, using molecular oxygen and NADPH. It can activate procarcinogens into carcinogenic metabolites.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 family 1 subfamily A polypeptide 1 (CYP1A1).